EVALUATION OF PYRAZOLE AND ETHANOL-INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING

被引:36
作者
BURKE, DA
WEDD, DJ
HERRIOTT, D
BAYLISS, MK
SPALDING, DJM
WILCOX, P
机构
[1] Glaxo Group Research Limited, Ware
关键词
D O I
10.1093/mutage/9.1.23
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A major constitutive enzyme in the liver of the uninduced rat is cytochrome P450-2E1. This isozyme has been shown to metabolize a number of carcinogens, including low molecular weight nitrosamines and a number of compounds normally regarded as non-mutagenic in the Ames test, e.g. aniline, urethane and benzene. Using the standard induction procedures [Aroclor 1254 or a combination of phenobarbitone (PB) and beta-naphthoflavone (beta-NF)] the level of CYP2E1 in rat liver is actually suppressed and it has been suggested that this may account for the negative findings with these compounds in the Ames test. S9 fractions were prepared R om rats pre-treated with pyrazole or ethanol (inducers of CYP2E1) and then used in the Ames test (or pre-incubation modification) with urethane, acetaminophen, aniline, benzene, procarbazine and N-nitrosopyrrolidine. Both pyrazole and ethanol induced S9 were superior to PB/beta-NF-S9 and uninduced-S9 for the activation of N-nitrosopyrrolidine, a known CYP2E1 substrate. However, there was no evidence of mutagenic activity with urethane, aniline, benzene, procarbazine or acetaminophen. As these compounds have demonstrated genotoxicity in vivo, additional important metabolic pathways must be required which are not present in rat liver S9 fraction.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 42 条
[1]   METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST [J].
AMES, BN ;
MCCANN, J ;
YAMASAKI, E .
MUTATION RESEARCH, 1975, 31 (06) :347-363
[2]   MECHANISM OF DIMETHYLSULFOXIDE PROTECTION AGAINST ACETAMINOPHEN HEPATOTOXICITY [J].
ARNDT, K ;
HASCHEK, WM ;
JEFFERY, EH .
DRUG METABOLISM REVIEWS, 1989, 20 (2-4) :261-269
[3]   COMPARATIVE MUTAGENICITY OF N-NITROSAMINES IN A SEMISOLID AND IN A LIQUID INCUBATION SYSTEM IN PRESENCE OF RAT OR HUMAN TISSUE FRACTIONS [J].
BARTSCH, H ;
CAMUS, A ;
MALAVEILLE, C .
MUTATION RESEARCH, 1976, 37 (2-3) :149-162
[4]  
DAHL GA, 1980, CANCER RES, V40, P1194
[5]   INCREASED CATALYTIC ACTIVITY OF CYTOCHROME-P-450IIE1 IN PERICENTRAL HEPATOCYTES COMPARED TO PERIPORTAL HEPATOCYTES ISOLATED FROM PYRAZOLE-TREATED RATS [J].
DICKER, E ;
MCHUGH, T ;
CEDERBAUM, AI .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1073 (02) :316-323
[6]   ALTERNATIVES TO AROCLOR 1254-INDUCED S9 IN INVITRO GENOTOXICITY ASSAYS [J].
ELLIOTT, BM ;
COMBES, RD ;
ELCOMBE, CR ;
GATEHOUSE, DG ;
GIBSON, GG ;
MACKAY, JM ;
WOLF, RC .
MUTAGENESIS, 1992, 7 (03) :175-177
[7]   OXIDATION OF TOXIC AND CARCINOGENIC CHEMICALS BY HUMAN CYTOCHROME-P-450 ENZYMES [J].
GUENGERICH, FP ;
SHIMADA, T .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (04) :391-407
[8]   ROLE OF HUMAN CYTOCHROME-P-450-IIE1 IN THE OXIDATION OF MANY LOW-MOLECULAR-WEIGHT CANCER SUSPECTS [J].
GUENGERICH, FP ;
KIM, DH ;
IWASAKI, M .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (02) :168-179
[9]   SPECTRAL AND METABOLIC PROPERTIES OF LIVER-MICROSOMES FROM IMIDAZOLE-PRETREATED RABBITS [J].
HAJEK, KK ;
NOVAK, RF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (02) :664-672
[10]  
JOHANSSON I, 1988, CANCER RES, V48, P5387